Artificial intelligence (AI) technologies for assessing and triaging skin lesions referred to the urgent suspected skin cancer pathway: early value assessment

The 'comparative analysis of the accuracy of DERM and teledermatology' evidence gap was re-categorised from 'essential evidence for future committee decision making' to 'evidence that further supports committee decision making'.

The 'accuracy of DERM in people with black or brown skin' evidence gap was updated to specify Fitzpatrick skin types 5 and 6.

Several sections were updated to include data collection 'when the technology is implemented as an autonomous tool and when it is used with healthcare professional review'.

The implementation section was updated to align with the NHS England Implementation Toolkit.